Structure Therapeutics

The Sr Director will lead the development and execution of medical strategy for obesity and metabolic programs, including publication planning and evidence generation. They will serve as a key scientific expert, building relationships with KOLs and collaborating cross-functionally to support clinical development and commercial readiness.